| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 44.5242 | 25 |
| GSM780708 | Untreated after 4 days (C2_1) | 47.3635 | 38 |
| GSM780709 | Untreated after 4 days (C3_1) | 38.7782 | 4 |
| GSM780719 | Untreated after 4 days (C1_2) | 44.8451 | 26 |
| GSM780720 | Untreated after 4 days (C2_2) | 41.681 | 12 |
| GSM780721 | Untreated after 4 days (C3_2) | 38.3059 | 3 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 46.3249 | 34 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 38.7469 | 4 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 40.4545 | 8 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 46.674 | 35 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 50.7511 | 51 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 45.723 | 31 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 37.5904 | 2 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 44.7972 | 26 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 41.6078 | 12 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 38.6044 | 3 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 37.3196 | 2 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 43.583 | 20 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 41.4227 | 11 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 42.92 | 17 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 43.6869 | 21 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 42.0592 | 13 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 46.9831 | 37 |